A Single-dose Trial to Investigate the Safety and Tolerability of XEN-D0501 in Patients With Diabetes Mellitus Type 2
Clinical trial NCT03278158 · COMPLETED
Trial details
- NCT number
- NCT03278158
- Sponsor
- Pila Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-18
- Primary completion
- 2018-11-13
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.